Related Experiment Videos
Optic disc hemorrhages and generalized vascular disease
Kirsti Grødum1, Anders Heijl, Bo Bengtsson
1Department of Ophthalmology, Malmö University Hospital, Malmö, Sweden.
Journal of Glaucoma
|July 26, 2002
Summary
Platelet aggregation inhibitors were linked to optic disc hemorrhages in a large study. This finding may suggest a connection between these medications and vascular health or optic disc bleeding.
Area of Science:
- Ophthalmology
- Vascular Medicine
- Pharmacology
Background:
- Optic disc hemorrhages (ODH) are potential indicators of underlying health conditions.
- Medications for vascular disease and diabetes are widely used in older populations.
Purpose of the Study:
- To investigate the association between ODH and four medication classes: platelet aggregation inhibitors, antihypertensive agents, cholesterol-lowering medication, and antidiabetic agents.
- To explore potential links between these medications and generalized vascular disease.
Main Methods:
- A population-based screening of 32,918 individuals aged 57-79 in Malmö, Sweden, was conducted.
- Optic disc photographs were analyzed for hemorrhages.
- Logistic regression analysis was performed, adjusting for age and gender.
Main Results:
- A significant association was found between optic disc hemorrhages and the use of platelet aggregation inhibitors (OR 3.16, P < 0.0001).
- No significant association was observed between ODH and antihypertensive, cholesterol-lowering, or antidiabetic medications.
Conclusions:
- The use of platelet aggregation inhibitors is significantly associated with optic disc hemorrhages.
- This finding may suggest a link between these medications and generalized vascular disease or a direct effect on optic disc hemorrhage resorption or predisposition.